Terms: = Lymphoma AND PLCG1, PLC1, 5335, ENSG00000124181, PLC-II, Plcg1, PLCgamma1, PLC148
50 results:
1. [Mutation characteristics of angioimmunoblastic T-cell lymphoma: an analysis of 75 cases].
Shen X; Yi HM; Li AQ; Ouyang BS; Dong L; Wang CF
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):29-33. PubMed ID: 38178743
[No Abstract] [Full Text] [Related]
2. A frequent PLCγ1 mutation in adult T-cell leukemia/lymphoma determines functional properties of the malignant cells.
Prawiro C; Bunney TD; Kampyli C; Yaguchi H; Katan M; Bangham CRM
Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166601. PubMed ID: 36442790
[TBL] [Abstract] [Full Text] [Related]
3. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
[TBL] [Abstract] [Full Text] [Related]
4. Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation.
Peiris MN; Meyer AN; Warda D; Campos AR; Donoghue DJ
Oncotarget; 2022; 13():659-676. PubMed ID: 35574218
[TBL] [Abstract] [Full Text] [Related]
5. A computational in silico approach to predict high-risk coding and non-coding SNPs of human plcg1 gene.
Khan SM; Faisal AM; Nila TA; Binti NN; Hosen MI; Shekhar HU
PLoS One; 2021; 16(11):e0260054. PubMed ID: 34793541
[TBL] [Abstract] [Full Text] [Related]
6. Sensitization to Drug Treatment in Precursor B-Cell Acute Lymphoblastic Leukemia Is Not Achieved by Stromal NF-κB Inhibition of Cell Adhesion but by Stromal PKC-Dependent Inhibition of ABC Transporters Activity.
Ruiz-Aparicio PF; Uribe GI; Linares-Ballesteros A; Vernot JP
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500796
[TBL] [Abstract] [Full Text] [Related]
7. Recruitment of phospholipase Cγ1 to the non-structural membrane protein pK15 of Kaposi Sarcoma-associated herpesvirus promotes its Src-dependent phosphorylation.
Samarina N; Ssebyatika G; Tikla T; Waldmann JY; Abere B; Nanna V; Marasco M; Carlomagno T; Krey T; Schulz TF
PLoS Pathog; 2021 Jun; 17(6):e1009635. PubMed ID: 34143834
[TBL] [Abstract] [Full Text] [Related]
8. Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains.
Sakihama S; Morichika K; Saito R; Miyara M; Miyagi T; Hayashi M; Uchihara J; Tomoyose T; Ohshiro K; Nakayama S; Nakachi S; Morishima S; Sakai K; Nishio K; Masuzaki H; Fukushima T; Karube K
Cancer Sci; 2021 Mar; 112(3):1300-1309. PubMed ID: 33426772
[TBL] [Abstract] [Full Text] [Related]
9. RLTPR Q575E: A novel recurrent gain-of-function mutation in patients with adult T-cell leukemia/lymphoma.
Uchida Y; Yoshimitsu M; Hachiman M; Kusano S; Arima N; Shima K; Hayashida M; Kamada Y; Nakamura D; Arai A; Tanaka Y; Hara H; Ishitsuka K
Eur J Haematol; 2021 Feb; 106(2):221-229. PubMed ID: 33098696
[TBL] [Abstract] [Full Text] [Related]
10. Clinical application of genomic aberrations in adult T-cell leukemia/lymphoma.
Kataoka K; Koya J
J Clin Exp Hematop; 2020 Sep; 60(3):66-72. PubMed ID: 32779615
[TBL] [Abstract] [Full Text] [Related]
11. MicroRNA‑126‑3p suppresses HeLa cell proliferation, migration and invasion, and increases apoptosis via the PI3K/PDK1/AKT pathway.
Ichikawa R; Kawasaki R; Iwata A; Otani S; Nishio E; Nomura H; Fujii T
Oncol Rep; 2020 Apr; 43(4):1300-1308. PubMed ID: 32323808
[TBL] [Abstract] [Full Text] [Related]
12. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous lymphoma Study Group.
Beltzung F; Ortonne N; Pelletier L; Beylot-Barry M; Ingen-Housz-Oro S; Franck F; Pereira B; Godfraind C; Delfau MH; D'Incan M; Vergier B
Am J Surg Pathol; 2020 Jul; 44(7):862-872. PubMed ID: 32271188
[TBL] [Abstract] [Full Text] [Related]
13. Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions.
Yoshida N; Shigemori K; Donaldson N; Trevisani C; Cordero NA; Stevenson KE; Bu X; Arakawa F; Takeuchi M; Ohshima K; Yoda A; Ng SY; Weinstock DM
Blood; 2020 Apr; 135(17):1467-1471. PubMed ID: 31961925
[TBL] [Abstract] [Full Text] [Related]
14. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
[TBL] [Abstract] [Full Text] [Related]
15. High-throughput Sequencing of Subcutaneous Panniculitis-like T-Cell lymphoma Reveals Candidate Pathogenic Mutations.
Fernandez-Pol S; Costa HA; Steiner DF; Ma L; Merker JD; Kim YH; Arber DA; Kim J
Appl Immunohistochem Mol Morphol; 2019; 27(10):740-748. PubMed ID: 31702703
[TBL] [Abstract] [Full Text] [Related]
16. Frequent and Persistent plcg1 Mutations in Sézary Cells Directly Enhance PLCγ1 Activity and Stimulate NFκB, AP-1, and NFAT Signaling.
Patel VM; Flanagan CE; Martins M; Jones CL; Butler RM; Woollard WJ; Bakr FS; Yoxall A; Begum N; Katan M; Whittaker SJ; Mitchell TJ
J Invest Dermatol; 2020 Feb; 140(2):380-389.e4. PubMed ID: 31376383
[TBL] [Abstract] [Full Text] [Related]
17. c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis.
Lyle CL; Belghasem M; Chitalia VC
Cells; 2019 May; 8(5):. PubMed ID: 31126146
[TBL] [Abstract] [Full Text] [Related]
18. Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.
Pérez C; Mondéjar R; García-Díaz N; Cereceda L; León A; Montes S; Durán Vian C; Pérez Paredes MG; González-Morán A; Alegre de Miguel V; Sanz Anquela JM; Frias J; Limeres MA; González LM; Martín Dávila F; Beltrán M; Mollejo M; Méndez JR; González MA; González García J; López R; Gómez A; Izquierdo F; Ramos R; Camacho C; Rodriguez-Pinilla SM; Martínez N; Vaqué JP; Ortiz-Romero PL; Piris MA
Br J Dermatol; 2020 Jan; 182(1):147-155. PubMed ID: 31049933
[TBL] [Abstract] [Full Text] [Related]
19. Discovery of 7H-pyrrolo[2,3-d]pyrimidine derivatives as selective covalent irreversible inhibitors of interleukin-2-inducible T-cell kinase (Itk).
Tang G; Liu L; Wang X; Pan Z
Eur J Med Chem; 2019 Jul; 173():167-183. PubMed ID: 30999237
[TBL] [Abstract] [Full Text] [Related]
20. Candidate susceptibility variants in angioimmunoblastic T-cell lymphoma.
Donner I; Katainen R; Kaasinen E; Aavikko M; Sipilä LJ; Pukkala E; Aaltonen LA
Fam Cancer; 2019 Jan; 18(1):113-119. PubMed ID: 30097855
[TBL] [Abstract] [Full Text] [Related]
[Next]
